Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity-Reference-Cited by-同舟云学术

Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity

Published:2018-03 Issue:3 Volume:41 Page:349-353
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Bergamini Corinna¹^ORCID,Dolci Giulia¹,Rossi Andrea¹,Torelli Flavia¹,Ghiselli Luca¹,Trevisani Laura¹,Vinco Giulia¹,Truong Stella¹,La Russa Francesca²,Golia Giorgio¹,Molino Annamaria²,Benfari Giovanni¹,Ribichini Flavio Luciano¹

Affiliation:

1. Division of Cardiology, Department of Medicine; University of Verona; Verona Italy

2. Division of Oncology; Azienda Ospedaliera Universitaria Integrata di Verona; Verona Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.22872/fullpdf

Reference23 articles.

1. Global cancer statistics [published correction appears in CA Cancer J Clin. 2011;61:134];Jemal;CA Cancer J Clin.,2011

2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med.,2001

3. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC);Zamorano;Eur Heart J,2016

4. Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?;Ewer;J Clin Oncol.,2008

5. Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough;Eidem;J Am Soc Echocardiogr.,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab;Cardiovascular Toxicology;2024-05-02

2. Echocardiographic Assessment of Left Ventricular Function in Three Oncologic Therapeutic Modalities in Women with Breast Cancer: The ONCO-ECHO Multicenter Study;Journal of Clinical Medicine;2024-04-26

3. Progress in the Use of Echocardiography in Patients with Tumors;Reviews in Cardiovascular Medicine;2024-01-15

4. Left atrial strain is reduced following trastuzumab in breast cancer patients;Echocardiography;2024-01

5. Left Atrial Volume Index, Other Systolic and Diastolic Transthoracic Echocardiographic Parameters as Early Predictors for Asymptomatic Trastuzumab Target Cancer Therapy-Related Cardiac Dysfunction among HER2-Positive Breast Cancer Patients at a Tertiary Medical Center in Metro Manila – a Single-Center Prospective Cohort Study;2023-07-25